A systematic literature review of prognostic factors in patients with HR+/HER2- advanced breast cancer in Japan.

Masaya HattoriDiego NovickKana TakauraYoshinori TanizawaTsutomu KawaguchiJosep Maria HaroAnna Monistrol-MulaAkira OnishiHiroji Iwata

Published in: Japanese journal of clinical oncology (2021)

Disease-free interval, the number of metastatic organs and liver metastasis were identified as independent prognostic factors for overall survival. These findings may help clinical decision-making to improve outcomes in patients with HR+/HER2- advanced and metastatic breast cancer.

Keyphrases

prognostic factors
metastatic breast cancer
decision making
squamous cell carcinoma
small cell lung cancer
type diabetes
free survival
adipose tissue
young adults
glycemic control
breast cancer risk